Key result
Far-ultraviolet laser radiation ablates atherosclerotic lesions without causing typical visible-laser thermal damage.
Answers are grounded in this paper and cite their sources.
Far-ultraviolet (far-UV) (193 nm) laser radiation ablates arterial wall tissue, including noncalcified atherosclerotic lesions, with no apparent thermal damage to remaining tissue. This effect contrasts sharply with the thermal damage produced by visible-wavelength laser irradiation. The mechanism by which far-UV radiation interacts with tissue is predominantly photochemical rather than photothermal. Potential clinical applications include those in which geometrically precise removal of tissue, without thermal damage to the remaining substrate, is desired. Ultraviolet laser catheterization appears practical with respect to the availability of fiberoptic materials and high-pulse-rate excimer lasers.
No takes yet. Share an insight, caveat, or question.
Linsker et al. (1984) studied Atherosclerotic lesions. Far-ultraviolet (193 nm) laser radiation vs. Visible-wavelength laser irradiation was evaluated on Thermal damage to tissue. Far-ultraviolet (193 nm) laser radiation ablates atherosclerotic lesions via photochemical mechanisms without the thermal damage typically produced by visible-wavelength lasers.
Synapse has enriched 10 related papers. Consider them for comparative context: